lawsuit tirzepatide After Lawsuit, FDA to Reconsider Shortage Issue Lilly asks to join lawsuit

Studies comparing semaglutide-only groups to semaglutide-plus-exercise groups show 812% greater weight reduction when activity is included

Dusigtumab (MEDI-573) and Xentuzumab (BI-836845) are dual IGF-I/IGF-II neutralizing antibodies which have now entered clinical trial

India's expanding pharma industry has led to a rise in the need for organized warehousing and logistics

Eat meals high in fiber: Viscous fiber, a type of soluble fiber that forms a gel in your body that gets things moving, can also help manage blood glucose and lipid levels, according to a 2023 study in Frontiers in Nutrition

B., Cai, Y

No dosage adjustment was necessary for adolescents (1518 years) with obese body weights according to the simulation results